Entera Bio (ENTX) Depreciation & Amortization (CF) (2021 - 2026)
Entera Bio (ENTX) recorded quarterly Depreciation & Amortization (CF) of $7000.0 in Q1 2026, little changed on a QoQ basis from $7000.0 in Q4 2025, and down 12.5% year-over-year from $8000.0 in Q1 2025.
Entera Bio (ENTX) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Entera Bio has disclosed Depreciation & Amortization (CF) across 6 years of filings, most recently posting $7000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 12.5% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29000.0 (down 29.27% YoY) and the FY2025 annual result came in at $30000.0, down 34.78% from the prior year.
- Depreciation & Amortization (CF) steadied at $7000.0 in Q1 2026, from $7000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $16000.0 in Q1 2022 and troughed at $7000.0 in Q2 2025.
- A 5-year average of $11941.2 and a median of $13000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 77.78% — and 2025, when it slumped 38.46%.
- Tracing ENTX's Depreciation & Amortization (CF) over 5 years: stood at $16000.0 in 2022, then decreased by 18.75% to $13000.0 in 2023, then dropped by 15.38% to $11000.0 in 2024, then tumbled by 36.36% to $7000.0 in 2025, then changed by 0.0% to $7000.0 in 2026.
- Business Quant data shows ENTX's Depreciation & Amortization (CF) at $7000.0 in Q1 2026, $7000.0 in Q4 2025, and $8000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 429,663.65 |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Dec 31, 2023 | 13,000.00 |